Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.
about
Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectivesClinical applications of transient elastographyCurrent and future directions for treating hepatitis B virus infectionNon-invasive prediction of forthcoming cirrhosis-related complications.Non-invasive assessment of liver fibrosis in chronic hepatitis B.Diagnostic usefulness of real-time elastography for liver fibrosis in chronic viral hepatitis B and C.Development of a non-invasive fibrosis test for chronic hepatitis B patients and comparison with other unpatented scores.Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model.Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study.Occult cirrhosis diagnosed by transient elastography is a frequent and under-monitored clinical entity.The feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinationsThe frequency and determinants of liver stiffness measurement failure: a retrospective study of "real-life" 38,464 examinations.Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study.Points to be considered when applying FibroScan S probe in children with biliary atresia.Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease.Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease.Performance of transient elastography assessing fibrosis of single hepatitis B virus infection: a systematic review and meta-analysis of a diagnostic test.Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis.Impact of Hepatitis C Virus Infection on Cognitive Function in Patients With Covert Hepatic Encephalopathy.Development of a model based on biochemical, real‑time tissue elastography and ultrasound data for the staging of liver fibrosis and cirrhosis in patients with chronic hepatitis B.Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy.Clinical benefit of liver stiffness measurement at 3 months after Kasai hepatoportoenterostomy to predict the liver related events in biliary atresia.Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis.Hepatitis B: are non-invasive markers of liver fibrosis reliable?Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease.Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.Contemporary use of elastography in liver fibrosis and portal hypertension.Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan(®)).Critical comparison of elastography methods to assess chronic liver disease.Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.Measuring spleen stiffness to predict varices in chronic hepatitis B cirrhotic patients with or without receiving non-selective beta-blockers.Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy.Hepatitis B cure: From discovery to regulatory approval.Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study.Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test.Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy.JSH Guidelines for the Management of Hepatitis B Virus Infection.Clinical characteristics of antimitochondrial antibody-positive patients at a safety net health care system in Arizona.Prediction of minimal hepatic encephalopathy.Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus.
P2860
Q26822664-3192B60A-4202-426E-B7CF-70CF2409B2C4Q26828052-FA1B8E34-C4CC-4C96-9A9B-F5A437A41089Q26851240-B340CB42-79B6-4F13-BD9A-CFE95783AE20Q27000645-FD56F6E9-6E4C-46F0-9547-69DD731D344BQ30427489-42025AFA-6454-439D-8874-9357B05F87ECQ30431813-84329FCB-630B-48FF-A29A-8BFFC55FEAB2Q30453789-C1E2CB35-CD46-4EE7-A4B2-7FD0A5849E31Q31164960-4AD84B6F-87FC-4910-AEEB-F81ED5BAAF4BQ33418708-9A4B09BF-14D5-4157-BFF9-1D1B72352903Q33420367-CB80CAD3-801C-4B85-8168-FBFC16ADF2F1Q33810066-21D90DC5-CAFF-4E95-A175-45DB14F3144FQ34047077-D7F33AD0-8010-447E-AF11-80A866341A89Q34450720-F13699E1-C56A-4E89-A00F-850AB9E59544Q34464647-961DDD6A-82BF-4922-B6F3-1EA2373FFA80Q35054972-7C566468-C7E6-4DA7-AD2E-E7A446C3DBBCQ35155090-8C522780-ED54-4E40-841D-5643E55F5E49Q35695535-A1877670-5F3A-41A1-88EF-67E2299C1CF9Q35862847-6E66554F-2676-458C-A5F3-7364D8F4E1CAQ35964960-FCB744E5-4104-4803-B5BA-6B93C8F83E74Q36116441-9433BFB4-790C-4C22-823F-54479D5F6463Q37205302-205EF03C-B031-4756-BCA9-789ABA732A52Q37321120-FAD632BB-F56A-44AB-A46F-387451E1B8A8Q37511482-7605040E-A37A-4175-ABDE-28BA8E82A1C1Q38174256-AB91E2AA-EA52-4635-8B00-9EA64011EECBQ38221077-59854FFF-85A4-448B-9186-2D6CA6E25F40Q38224416-BF306DB3-5898-4D71-98CE-26A4732B7123Q38605327-9BF60591-03F8-40CC-8719-356AC9AA9FD0Q38635589-241DD88B-699D-4742-98CB-45F155110710Q38858344-0ECD1599-A1E4-47D0-B8F5-5ACFB6F1C794Q40259385-9B2CEAE2-2091-4D1F-9D27-813386BD7A3EQ40537499-192F7B90-B409-4510-BBC6-A93D3FF3C196Q41065754-76736EDE-7A26-453E-94EB-48271A0B46B2Q41952398-7CB15F5C-2466-4C1D-BA98-3814267327FFQ42164803-5DF18580-9B1F-4728-A47A-446CC93A1CADQ42198890-BDDBBE15-322C-47C8-A90C-B4133D755CE5Q42210609-E15DD229-EBFA-4588-80E8-50965401E74AQ42244740-BD6A17E6-970A-44F3-B9FE-9075B44FAE6AQ42272368-BBDBAF24-593F-4B89-9E0F-E8273F7F2A58Q42331655-15A73E31-6D7B-4B32-AEC9-99BE37C7529EQ43419593-8F635C38-6DAE-4D74-BA00-3A4EC975CC4B
P2860
Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Prediction of liver-related ev ...... owing advanced liver fibrosis.
@ast
Prediction of liver-related ev ...... owing advanced liver fibrosis.
@en
Prediction of liver-related ev ...... owing advanced liver fibrosis.
@nl
type
label
Prediction of liver-related ev ...... owing advanced liver fibrosis.
@ast
Prediction of liver-related ev ...... owing advanced liver fibrosis.
@en
Prediction of liver-related ev ...... owing advanced liver fibrosis.
@nl
prefLabel
Prediction of liver-related ev ...... owing advanced liver fibrosis.
@ast
Prediction of liver-related ev ...... owing advanced liver fibrosis.
@en
Prediction of liver-related ev ...... owing advanced liver fibrosis.
@nl
P2093
P2860
P50
P1433
P1476
Prediction of liver-related ev ...... howing advanced liver fibrosis
@en
P2093
Chae Yoon Chon
Do Young Kim
Ji Hoon Lee
Jun Yong Park
Kyu Sik Jung
Seung Up Kim
Young Nyun Park
P2860
P304
P356
10.1371/JOURNAL.PONE.0036676
P407
P577
2012-05-04T00:00:00Z